Lubec G, Weissenbacher G, Balzar E
Wien Klin Wochenschr. 1977 Jan 21;89(2):49-53.
The serum and urine levels of alpha-2-macroglobulin (alpha2-MG) was determined in 33 children with glomerular diseases and in 26 healthy control children. Healthy children showed a minimum level of 275 mg% and maximum level of 337 mg%, with a mean concentration of 301 mg% and a standard deviation of 13 mg%. No alpha2-MG was detected in the urine. Steroid-treated patients with idiopathic nephrotic syndrome displayed elevated inhibitor levels of up to 490 mg%. This might be a direct result of steroid therapy or a consequence of reactively-increased protein synthesis in response to the renal protein loss. In all these patients the urine was found to be alpha2-MG-negative, irrespective of the presence or absence of proteinuria. In the miscellaneous group of glomerulopathies without the nephrotic syndrome, serum levels of alpha2-MG were shown to be normal. The urinary concentrations of alpha2-MG were related to the activity of the disease. alpha2-MG determination in serum and urine seems to be a tool for differential diagnosis and prognosis in some cases of glomerular disease.
对33例肾小球疾病患儿和26例健康对照儿童测定了血清和尿液中的α2-巨球蛋白(α2-MG)水平。健康儿童的最低水平为275mg%,最高水平为337mg%,平均浓度为301mg%,标准差为13mg%。尿液中未检测到α2-MG。接受类固醇治疗的特发性肾病综合征患者的抑制剂水平升高至490mg%。这可能是类固醇治疗的直接结果,也可能是对肾脏蛋白质丢失反应性增加的蛋白质合成的结果。在所有这些患者中,无论是否存在蛋白尿,尿液均为α2-MG阴性。在无肾病综合征的其他肾小球疾病组中,α2-MG的血清水平显示正常。α2-MG的尿液浓度与疾病活动度相关。血清和尿液中α2-MG的测定似乎是某些肾小球疾病病例鉴别诊断和预后评估的一种工具。